GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52 | -45.3% | 13,594 | -21.9% | 0.00% | – |
Q2 2023 | $95 | -26.9% | 17,395 | -42.4% | 0.00% | – |
Q1 2023 | $130 | +154.9% | 30,186 | +133.8% | 0.00% | – |
Q4 2022 | $51 | -99.5% | 12,913 | +533.0% | 0.00% | – |
Q3 2022 | $11,000 | -35.3% | 2,040 | -19.5% | 0.00% | – |
Q2 2022 | $17,000 | -68.5% | 2,534 | -65.2% | 0.00% | – |
Q1 2022 | $54,000 | – | 7,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |